WELCOME ADDRESS
DOES THE OCCURENCE OF POSTTRANSPLANT DE NOVO DONOR-SPECIFIC HLA ANTIBODIES DEPEND ON THE IMMUNOSUPPRESSIVE REGIMEN IN IMMUNOLOGICALLY LOW-RISK PATIENTS?
ECULIZUMAB BRIDGING AND PLASMA CELL-DIRECTED THERAPY - A NOVEL CONCEPT IN SEVERE ANTIBODY MEDIATED REJECTION IN KIDNEY TRANSPLANTATION
EARLY EVEROLIMUS PLUS REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS RESULTS IN SUPERIOR RENAL FUNCTION AND SUSTAINS OVER 24 MONTHS: RESULTS OF A RANDOMIZED TRIAL
EVEROLIMUS PLUS REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS ACHIEVES COMPARABLE OVERALL EFFICACY WITH FEWER BIOPSY-PROVEN ACUTE REJECTIONS VERSUS STANDARD TACROLIMUS: 24-MONTH RESULTS OF A RANDOMIZED TRIAL
THE PROTECT STUDY: EFFECT OF 35 MONTH EVEROLIMUS MONOTHERAPY VS. CALCINEURIN INHIBITOR-BASED THERAPY ON EFFICACY AND RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS
SELECTIVE INHIBITION OF NFATC1 ACTIVATION IN RECIPIENT T-CELLS PROLONGS GRAFT SURVIVAL IN A MOUSE MODEL OF HETEROTOPIC HEART TRANSPLANTATION
THE PROGNOSTIC VALUE OF GLOMERULAR AND TUBULAR PROTEINURIA IN DECEASED DONOR KIDNEYS IN PREDICTING THE OUTCOME TWELVE MONTHS AFTER TRANSPLANTATION ESPECIALLY OF MARGINAL DONOR KIDNEYS
“OLD- TO OLD” ALLOCATION IN PANCREAS TRANSPLANTATION- IMPACT OF DIFFERENT CUTOFF AGES
SUBNORMOTHERMIC EX VIVO LIVER PERFUSION (SNEVLP) REDUCES ISCHEMIA/REPERFUSION INJURY IN LIVERS RETRIEVED AFTER CARDIAC DEATH (DCD)
MELD SPECIFIC OUTCOMES BEFORE AND AFTER INTRODUCTION OF MELD-BASED ALLOCATION
PREVALENCE OF HEPATITIS C IN GERMAN ORGAN-DONORS
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: CLINICOPATHOLOGICAL ANALYSIS OF 54 CASES IN A SINGLE CENTER
UREA-MODIFIED PROTEIN ANTIGENS FOR SIMULTANEOUS ASSESSMENT OF CMV-SPECIFIC CD4 AND CD8 T-CELL RESPONSES USING A NEW CMV-ELISPOT ASSAY AND FLOW-CYTOMETRY
MICAFUNGIN AS ANTIFUNGAL PROPHYLAXIS IN HIGH-RISK LIVER TRANSPLANTATION: A RANDOMISED MULTICENTRE TRIAL
DAILY LOW-DOSE TACROLIMUS (TAC) IS A SAFE AND EFFICIENT IMMUNOSUPPRESSIVE REGIMEN DURING HCV TRIPLE DRUG THERAPY POST LIVER TRANSPLANT - A 24 WEEKS INTERIM ANALYSIS
A MODEL TO IDENTIFY PATIENTS AT RISK FOR POST-TRANSPLANT KIDNEY DISEASE AFTER LIVER TRANSPLANTATION
DROP-OUTS IN ABO-INCOMPATIBLE (ABOI) LIVING-DONOR RENAL TRANSPLANTATION MAY BE PREVENTED - A SINGLE CENTER EXPERIENCE
POST HOC SUBGROUP ANALYSIS FROM ZEUS: OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN
DONOR QUALITY OF LIFE UP TO TWO YEARS AFTER LIVING DONOR LIVER TRANSPLANTATION: A PROSPECTIVE STUDY
EXPERIENCE WITH LIVING DONOR LIVER TRANSPLANTATION (LD-LTX) FOR RE-TRANSPLANTATIONS
DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING BEFORE AND AFTER DONOR NEPHRECTOMY: LONGITUDINAL FOLLOW-UP REVEALS FUNCTIONAL CHANGES OF THE REMAINING KIDNEY IN DONORS
LIVING RENAL DONATION: IMPACT ON THE EMOTIONAL STATUS OF THE DONOR
DETECTION OF ALCOHOL CONSUMPTION IN LIVER TRANSPLANT RECIPIENTS USING DETERMINATION OF ETHYL GLUCURONIDE CONCENTRATION IN URINE AND HAIR
PREDICTION OF MORTALITY AFTER LIVER TRANSPLANTATION IN THE MELD-ERA: A MULTIVARIATE RISK ASSESSMENT
VOLUME AND OUTCOME RELATION IN GERMAN LIVER TRANSPLANT CENTERS: MUCH ADO ABOUT NOTHING?
OUTCOME OPTIMIZATION OR URGENCY - WHAT MATTERS MORE IN THE ALLOCATION OF DONOR LIVERS. A SURVEY AMONG OUTPATIENTS OF A MEDICAL UNIVERSITY DEPARTMENT
THE GERMAN TRANSPLANT SCANDAL: REFLECTIONS OF AN INSIDER
QUALITY OF LIFE AFTER LIVER TRANSPLANTATION
BEHAVIOURAL PROBLEMS AFTER PEDIATRIC LIVER TRANSPLANTATION (PLTX) - RELATED TO CALCINEURIN INHIBITOR (CNI) THERAPY?
C-TERMINAL AGRIN FRAGMENT (CAF) - A NEW BIOMARKER FOR EVALUATING KIDNEY FUNCTION IN RENAL TRANSPLANT RECIPIENTS
URINARY CALPROTECTIN DIFFERENTIATES BETWEEN PRERENAL AND INTRINSIC ACUTE RENAL ALLOGRAFT FAILURE
CLINICALLY RELEVANT BKV-REPLICATION EVENTS IN RENAL TRANSPLANT RECIPIENTS ARE ASSOCIATED WITH SIGNIFICANT CHANGES IN T-CELL FUNCTIONALITY
INFLUENCE OF DONOR NEPHRON MASS INDEX OF KIDNEY FUNCTION AFTER TRANSPLANTATION - A PROSPECTIVE STUDY
PREDICTION OF CARDIOVASCULAR EVENTS AFTER RENAL TRANSPLANTATION
SIGNIFICANT IMPACT OF PROLONGED BRAIN DEATH DURATION ON PATIENT SURVIVAL AFTER KIDNEY TRANSPLANTATION
SINGLE CENTER STUDY: OUTCOME AFTER 428 COMBINED PANCREAS-KIDNEY-TRANSPLANTATIONS
125 CASES OF DUODENODUODENOSTOMY IN PANCREAS TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE OF AN ALTERNATIVE ENTERIC DRAINAGE
TRANSPLANTING ALLO-ISLETS WITHOUT IMMUNOSUPPRESSION
ISLET AUTOTRANSPLANTATION AFTER COMPLETE PANCREATECTOMY FOR COMPLICATIONS OF UPPER GI-TRACT SURGERY
MICB - A LIGAND FOR THE ACTIVATING NATURAL KILLER RECEPTOR NKG2D - IS A MARKER FOR THE PREDICTION OF GRAFT REJECTION AFTER COMBINED KIDNEY-PANCREAS TRANSPLANTATION
TWENTY-YEAR LONGITUDINAL FOLLOW-UP AFTER ORTHOTOPIC LIVER TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE OF 313 CONSECUTIVE CASES
LONG TERM SURVIVAL AFTER LIVER TRANSPLANTATION WITH AORTIC CONDUITS
DO WE HAVE RELIABLE CRITERIA TO AVOID RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION?
PRE-TRANSPLANT TREATMENT OF HEPATOCELLULAR CARCINOMA WITH RADIOEMBOLIZATION USING YTTRIUM-90 MICROSPHERES
ROUTINE CHOLANGIOSCOPY AS PART OF THE PERCUTANEOUS TRANSHEPATIC MANAGEMENT OF BILIARY STRICTURES AFTER LIVER TRANSPLANTATION UNTREATABLE BY ENDOSCOPIC RETROGRADE CHOLANGIOGRAPHY - A PROSPECTIVE SINGLE CENTRE EVALUATION
COMPLICATIONS OF ENDOSCOPIC SPHINCTEROTOMY (EST) IN PATIENTS AFTER LIVER TRANSPLANTATION (LT)
TRANSTHYRETIN ASSOCIATED HEREDITARY AMYLOIDOSIS IN A GERMAN COHORT
TELAPREVIR BLOOD LEVELS ARE UNALTERED IN PATIENTS WITH CICLOSPORIN AND TACROLIMUS BASED IMMUNOSUPPRESSION AFTER ORTHOTOPIC LIVER TRANSPLANTATION
BRAIN DRAIN OUT OF LIVER TRANSPLANT SURGERY IN GERMANY
ADULT TO ADULT LEFT LDLT (AA-LEFT-LDLT): SINGLE CENTRE EXPERIENCE AT UNIVERSITY HOSPITAL TÜBINGEN
DOPPLER ULTRASOUND FINDINGS IN CHILDREN WITH EARLY LIVER GRAFT FAILURE
SMALL BOWEL TRANSPLANTATION: INDICATIONS AND LIMITATIONS
HIGH NEGATIVE PREDICTIVE VALUE OF CARDIAC MRI IN DETECTION OF SUB-CLINICAL ACUTE REJECTION AFTER HEART TRANSPLANTATION
C4D DEPOSITION CORRELATES TO MICROVASCULOPATHY IN CORONARY ANGIOGRAPHY AND BIOPSY AFTER HEART TRANSPLANTATION
MANAGEMENT OF THORACIC TRANSPLANT PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT-II): EXPERIENCE WITH PREOPERATIVE PLASMAPHERESES PLUS INTRAOPERATIVE HEPARIN
CLINICAL OUTCOME IN HEART TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS IN COMBINATION WITH THE CALCINEURIN INHIBITOR TACROLIMUS OR CYCLOSPORIN A
BRIDGE TO LUNG TRANSPLANTATION WITH A BI-CAVAL DUAL LUMEN CATHETER FOR VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION IN NON-INTUBATED PATIENTS: A SINGLE CENTER EXPERIENCE
CARDIOGONIOMETRY: A POTENTIAL NON-INVASIVE SCREENING TOOL FOR THE DIAGNOSIS OF CARDIAC ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS
LEVEL OF INFORMATION OF STUDENTS AT THE UNIVERSITY OF REGENSBURG CONCERNING ORGAN DONATION AND TRANSPLANTATION - INFORMED OR NOT INFORMED CONSENT IN ORGAN DONATION?
EVALUATION OF IFNγ RELEASE ASSAYS FOR DETECTION OF CELLULAR IMMUNITY TOWARDS M. TUBERCULOSIS AND CMV IN SAMPLES FROM DECEASED DONORS
5 YEARS FOLLOW-UP ON RENAL FUNCTION - ZEUS TRIAL: IMPROVED RENAL FUNCTION OF AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS
HERAKLES AT MONTH 24: FOLLOW-UP RESULTS ON EFFICACY AND SAFETY OF THREE DIFFERENT TREATMENT REGIMENS IN DE NOVO RENAL TRANSPLANT PATIENTS DEMONSTRATE OPTIONS FOR INDIVIDUALIZED IMMUNSOSUPPRESSION
A POST HOC ANALYSIS OF 2 PROSPECTIVE, OPEN-LABEL, MULTICENTER, RANDOMIZED TRIALS: ONSET AND PROGRESSION OF DIABETES IN KIDNEY TRANSPLANT PATIENTS RECEIVING EVEROLIMUS OR CYCLOSPORINE. RESULTS FROM ZEUS AND HERAKLES
4 YEAR DATA OF THE APOLLO TRIAL: OUTCOME ON RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS
MTOR INHIBITION AND EVOLUTION OF URINARY PROTEIN EXCRETION IN NON-RENAL TRANSPLANT PATIENTS
EFFECT ON AN EVEROLIMUS- VS. MMF-BASED STEROID-FREE IMMUNOSUPPRESSIVE REGIMEN ON LONGITUDINAL GROWTH IN PAEDIATRIC RENAL TRANSPLANT RECIPIENTS
PHARMACODYNAMIC MONITORING OF MTOR INHIBITION BY PHOSPHOFLOW CYTOMETRIC DETERMINATION OF P70S6 KINASE ACTIVITY
COMPARISON OF THE SINGLE ANTIGEN BEAD LUMINEX ASSAY AND ELISA IN PATIENTS ON THE KIDNEY WAITING LIST AND WITH A KIDNEY TRANSPLANTATION
CLINICAL OUTCOME IN MAJOR HISTOCOMPATIBILITY COMPLEX ANTIBODY POSITIVE HEART TRANSPLANT RECIPIENTS RECEIVING THYMOGLOBIN FOR INDUCTION THERAPY
ANTI-HLA ANTIBODY-DEPENDENT INDUCTION OF VASCULAR CELL ADHESION MOLECULE-1 EXPRESSION IS MODULATED BY HEME OXYGENASE-1 IN HUMAN ENDOTHELIAL CELLS
HIGHLY PURE HUMAN ANTIGEN-SPECIFIC TREGS WITH SUPERIOR FUNCTION IN PREVENTING ALLOGRAFT REJECTION
AUTOIMMUNE TARGETING OF PROTEASE ACTIVATED RECEPTOR-1 (PAR-1) DEREGULATES VEGF AND DISTURBS NEOANGIOGENESIS
SILENCING HLA CLASS I EXPRESSION IN HUMAN CORNEAS TO DECREASE THE RISK OF GRAFT REJECTION AFTER KERATOPLASTY
INTRAGRAFT CD11C+ DENDRITIC CELLS TRIGGER A MORE POTENT IL-17 MEDIATED IMMUNE RESPONSE WHEN TRANSPLANTATING ORGANS FROM OLDER DONORS
DENDRITIC CELLS AS BIOMARKERS FOR ACUTE CELLULAR REJECTION AFTER HEART TRANSPLANTATION
PPARγ-DEPENDENT INHIBITION OF CYTOTOXIC T CELLS
DEVELOPING A BIOHYBRID LUNG - ENDOTHELIALIZATION WITH ALLOGENEIC MHC-SILENCED ENDOTHELIAL CELLS TO PREVENT TRANSPLANT REJECTION
PHOSPHORYLCHOLINE-MODIFIED MACROMOLECULES INHIBIT THE ATP-DEPENDENT IL-1β RELEASE IN HUMAN MONOCYTES
THE EFFECT OF PRESERVATION SOLUTIONS HTK, HTK-N AND TIPROTEC ON VARIOUS TISSUES AFTER RAT HIND-LIMB ALLOTRANSPLANTATION
EFFICACY OF HEPATOCYTE TRANSPLANTATION IS INCREASED BY PHARMACOLOGICAL PRECONDITIONING OF THE HOST LIVER
ENGINEERED MSCS: INNOVATIVE HCC THERAPY AND POTENTIAL BRIDGING PROCEDURE BEFORE LIVER TRANSPLANTATION?
DONOR BRAIN DEATH RESULTS IN DIFFERENTIALLY MODULATED IMMUNE ACTIVATION IN SOLID ORGANS
INFLUENCE OF NORMOTHERMIC, MILD- AND SEVERE HYPOTHERMIC CONDITIONS ON TRANSENDOTHELIAL MIGRATION: WHAT ABOUT THE REWARMING DURING REPERFUSION?
TWO SEPARATE PATHWAYS OF REGULATED NECROSIS CONTRIBUTE TO ISCHEMIA-REPERFUSION INJURY
EX-VIVO INHIBITION OF RHO-KINASE DURING RENAL PRESERVATION IMPROVES GRAFT FUNCTION UPON REPERFUSION
ANTIBODY MEDIATED REJECTION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION
DSA CLEARANCE AND FUNCTIONAL RECOVERY OF A KIDNEY TRANSPLANT FROM SEVERE ACUTE HUMORAL REJECTION UNDER A COMBINED TREATMENT WITH ECULIZUMAB AND BELATACEPT
FOLLOW-UP DATA FROM HERAKLES STUDY AT MONTH 24: MAINTAINED SUPERIOR RENAL FUNCTION IN PATIENTS ON AN EVEROLIMUS-BASED CALCINEURIN INHIBITOR FREE REGIMEN COMPARED TO STANDARD CYCLOSPORINE/MYCOPHENOLATE AND LOW CYCLOSPORINE/EVEROLIMUS
TACROLIMUS - GENERIC OR ORIGINAL, IS THERE A DIFFERENCE?
DOSE/TIME-DEPENDENT MODULATION OF THE ENDOTHELIAL FUNCTION THROUGH INDUCTION AGENTS: NON-DEPLETING VS. DEPLETING AGENTS
COMPREHENSIVE ANALYSIS OF GENETIC VARIANTS INFLUENCING PLASMA LEVEL OF TACROLIMUS IN KIDNEY TRANSPLANTATION
EFFECTS OF RECIPIENTS' MDR1 AND CYP3A5 GENOTYPES ON TACROLIMUS DOSE REQUIREMENTS AFTER LIVER TRANSPLANTATION
INFLUENCE OF THE TACROLIMUS METABOLISM RATE ON THE RENAL FUNCTION AFTER KIDNEY TRANSPLANTATION
NO ASSOCIATION BETWEEN CTLA-4 AND PDCD1 POLYMORPHISMS AND ACUTE REJECTION IN GERMAN LIVER TRANSPLANT RECIPIENTS
CAPABILITY FOR ANTIBODY DETECTION IN ELUATES OBTAINED BY IMMUNOADSORPTION (IA)
POLYMORPHIC VARIATIONS OF SEMAPHORIN 7A ALTER ITS FUNCTION IN THE REGULATION OF ANTIGEN PRESENTATION AND EFFECTOR IMMUNE RESPONSE
IMPACT OF PRE-SENSITIZATION, TIME ON WAITING LIST AND HAEMODIALYSIS ON PRE-TRANSPLANT AS WELL AS OF GRAFT FUNCTION ON POST-TRANSPLANT SERUM KYNURENINE LEVEL IN KIDNEY GRAFT RECIPIENTS
PREFORMED CELLULAR ALLOREACTIVITY IS DOMINATED BY CD8 T-CELLS AND IS MORE FREQUENTLY OBSERVED IN RENAL TRANSPLANT CANDIDATES AS COMPARED TO CONTROLS
REFRACTORY REJECTION AND POSITIVE HLA-ANTIBODIES IN A PEDIATRIC PATIENT AFTER REPEATED LIVER TRANSPLANTATIONS - EVIDENCE FOR HUMORAL REJECTION?
DURING ACUTE CELLULAR REJECTION HLA-E IS EXPRESSED IN KIDNEY GRAFTS*
SUCCESSFUL PANCREAS/KIDNEY RE-TRANSPLANTATION BY A PATIENT WITH VERY HIGH PANEL REACTIVE ANTIBODIES. OUR DESENSITIZATION PROTOCOL.
TUMOR INCIDENCE IN HEART TRANSPLANT RECIPIENTS RECEIVING CYCLOSPRIN A OR TACROLIMUS AS MAINTENANCE THERAPY
THREE-YEAR FOLLOW-UP RESULTS IN HEART TRANSPLANT RECIPIENTS RECEIVING TACROLIMUS RETARD (ADVAGRAF®)
TUMOR INCIDENCE IN HEART TRANSPLANT RECIPIENTS RECEIVING SIROLIMUS OR EVEROLIMUS AS MAINTENANCE THERAPY
CLINICAL OUTCOME IN HEART TRANSPLANT RECIPIENTS WITH CHRONIC KIDNEY DISEASE RECEIVING THYMOGLOBIN FOR INDUCTION THERAPY
IMPACT OF EXTRACORPORAL PHOTOPHERESIS IN HEART TRANSPLANT RECIPIENTS WITH DIFFERENT IMMUNE STATUS
PIRFENIDONE: A POTENTIAL THERAPY FOR PROGRESSIVE LUNG ALLOGRAFT DYSFUNCTION?
BILATERAL VERSUS SINGLE LUNG TRANSPLANTATION FOR IDIOPATHIC PULMONARY FIBROSIS
AV-VALVE SURGERY IN HEART TRANSPLANT RECIPIENTS
HU FAILURE VS. VAD FAILURE: EFFICACY AND SAFETY OF TREATMENT CONCEPTS FOR TERMINAL HEART FAILURE IN THE CURRENT ERA
THE IMPACT OF DONOR AND RECIPIENT PARAMETERS ON THE OUTCOME OF HEART TRANSPLANTATION IN GERMANY
PROCALCITONIN (PCT) IN COMBINATION WITH HIGHLY SENSITIVE CARDIAC TROPONIN T (HS-CTNT) TO DETECT PATIENTS AT RISK AFTER HEART TRANSPLANTION (HTX)
A COMPARISON OF CARDIAC TROPONIN I AND CREATINE KINASE-MB FOR SELECTION OF HEART DONORS AND AS PREDICTORS OF GRAFT FAILURE
MONITORING THE CYTOMEGALOVIRUS-SPECIFIC CELLULAR IMMUNITY IN LUNG TRANSPLANT RECIPIENTS: A COMPARATIVE ANALYSIS OF TWO ASSAY SYSTEMS
TREATMENT OF ASYMPTOMATIC CMV DNA POSITIVE INFECTIONS IN HEART TRANSPLANT RECIPIENTS WITH CMV HYPERIMMUNOGLOBULIN MONOTHERAPY (CYTOTECT©)
SUCCESSFUL TREATMENT OF EPSTEIN-BARR VIRUS (EBV) INFECTION WITH RITUXIMAB IN POST LUNG TRANSPLANT PATIENT WITH PREVIOUS B-CELL LYMPHOMA: A CASE REPORT
SUCCESSFUL TREATMENT OF CEREBRAL VENTRICULAR MUCORMYCOSIS IN A HEART-LUNG TRANSPLANT RECIPIENT
DEPRESSIVE SYMPTOMS AT TIME OF WAIT LISTING ARE ASSOCIATED WITH REDUCED SURVIVAL AFTER HEART TRANSPLANTATION: RESULTS FROM THE WAITING FOR A NEW HEART STUDY
REDUCTION OF OBLITERATIVE BRONCHIOLITIS (OB) BY PROLYL-HYDROXYLASE-INHIBITORS ACTIVATING HYPOXIA-INDUCIBLE TRANSCRIPTION FACTORS IN AN EXPERIMENTAL MOUSE MODEL
DEVELOPING A NOVEL XENOTRANSPLANTATION MODEL TO STUDY CHRONIC OBLITERATIVE AIRWAY DISEASE
COLLAGEN-PRODUCING HEMATOPOIETIC CELLS (FIBROCYTES) IN EXPERIMENTAL HEART TRANSPLANTATION AND THEIR REGULATION BY BASOPHILS
DEPLETION OF IMMUNE-MEDIATORS FROM DONOR LUNGS USING THE ORGAN CARE SYSTEM® - A POTENTIAL MECHANISM FOR IMPROVED OUTCOMES
HEART TRANSPLANTATION IN A YOUNG PATIENT WITH ANOREXIA NERVOSA - A PERSPECTIVE? A CASE REPORT
LIVER TRANSPLANTATION FROM DONORS WITH PAST HISTORY OF MALIGNANCY: A SINGLE CENTER EXPERIENCE
DEVELOPEMENT OF DONOR CRITERIA OF COMBINED PANKREAS-KIDNEY-DONATION WITHIN THE LAST 10 YEARS
DOUBLE LUNG TRANSPLANTATION FROM A DONOR SUPPORTED BY A LEFT VENTRICULAR ASSIST DEVICE
PORCINE MODEL FOR WHOLE-BLOOD NORMOTHERMIC EXTRACORPOREAL KIDNEY PERFUSION (NEKIP) - PERFUSION AFFECT ON T-CELL FREQUENCY OR FUNCTION
NEW STRATEGY FOR AB0-INCOMPATIBLE PAEDIATRIC LIVER TRANSPLANTATION
INFLAMMATORY RESPONSE AFTER BRAIN DEATH IS REDUCED BY DONOR TREATMENT WITH DESMOPRESSIN (DDAVP) IN AN ALLOGENIC KIDNEY TRANSPLANTATION MODEL IN RATS
DUAL KIDNEY TRANSPLANTATION WITHOUT PREIMPLANTATION BIOPSY: A SINGLE CENTER EXPERIENCE
HEPATITIS C INFECTED DONORS: KNOWLEDGE OF VIRAL-LOAD IMPROVES USE OF GRAFTS IN GERMANY
ARE MARGINAL DONORCRITERIA A RISKFACTOR FOR GRAFT THROMBOSIS IN PANCREAS-TRANSPLANTATION?
CONTACT BETWEEN DONOR FAMILIES AND ORGAN RECIPIENTS - EVALUATION 2010 - 2013, DSO MITTE REGION
PNEUMOCOCCAL AND HLA ANTIBODIES ARE PREDICTIVE OF KIDNEY TRANSPLANT OUTCOME
LOW-DOSE CIDOFOVIR AND CONVERSION TO MTOR IN POLYOMA VIRUS-ASSOCIATED NEPHROPATHY (PVAN) - A CASE SERIES
SEVERE APHTHOUS STOMATITIS RELATED TO HUMAN HERPES VIRUS 6 INFECTION IN A RENAL TRANSPLANT PATIENT
ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS (HIV)-POSITIVE PATIENTS IN GERMANY
ALTERED PHENOTYPE AND FUNCTIONALITY OF VARICELLA-ZOSTER VIRUS SPECIFIC CD4 T-CELLS IN PATIENTS WITH ACUTE HERPES ZOSTER
IDENTIFICATION OF NEW FACTORS THAT IMPACT SUBCUTANEOUS HBIG REQUIREMENT AFTER LIVER TRANSPLANTATION
ALLOGRAFT FAILURE IN AN INTESTINAL GRAFT RECIPIENT AFTER CYTOMEGALOVIRUS DISEASE WITHOUT DNAEMIA
BILE COLONIZATION IN LIVER TRANSPLANT PATIENTS UNDERGOING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATICOGRAPHY (ERCP): INCIDENCE, CLINICAL RELEVANCE AND ANTIBIOTIC SUSCEPTIBILITY
CMV INFECTION FOLLOWING LIVER TRANSPLANTATION: PREEMPTIVE THERAPY OR PROPHYLAXIS
THE GENETIC SIGNATURE OF THE DONOR ORGAN INFLUENCES THE FIBROSIS PROGRESSION AFTER LIVER TRANSPLANTATION
RECURRENT HEPATITIS C VIRUS GENOTYPE 1 INFECTION AFTER LIVER TRANSPLANTATION - WHOM TO TREAT?
INNOVATIVE CONSEQUENCES FOR CLINICAL PHARMACOLOGICAL APPROACH: HELP - HIERARCHICAL ELEMENTS FOR LONG-TERM PREVEILLANCE
TEXT MESSAGING MAY IMPROVE SUN PROTECTION ADHERENCE IN PEDIATRIC ORGAN TRANSPLANT RECIPIENTS
BK VIREMIA AND POLYOMAVIRUS NEPHROPATHY IN 352 KIDNEY TRANSPLANTS; RISK FACTORS AND POTENTIAL ROLE OF MTOR INHIBITION
PROPOSAL FOR HYGIENE MANAGEMENT OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) IN ORGAN DONATION AND PROCUREMENT
PNEUMONIA IN KIDNEY AND KIDNEY-PANCREAS TRANSPLANT PATIENTS
TELEMEDICAL SUPPORTED AFTER CARE IN LIVING KIDNEY RECIPIENTS - AN INNOVATIVE PROJECT-STUDY AT THE TRANSPLANTATIONCENTER FREIBURG INTERIM RESULTS OF A PROSPECTIVE ONGOING STUDY OF 50 PATIENTS
DESENSITIZATION PROTOCOL IN IMMUNIZED LIVING DONOR KIDNEY TRANSPLANTATION - A SINGLE CENTER EXPERIENCE
FIRST EXPERIENCE WITH ABO INCOMPATIBLE LIVING RELATED KIDNEY TRANSPLANTATION (ABOI) WITHOUT RITUXIMAB IN HAMBURG
AB0-INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTION AT THE TRANSPLANT CENTER OF ERLANGEN-NUREMBERG - A SINGLE CENTER EXPERIENCE OVER 7 YEARS
HAND-ASSITED TWO-PORT RETROPERITONEOSCOPIC LIVING DONOR NEPHRECTOMY: STILL CONDEMNED TO THE LEFT SIDE?
COMPARISON OF GLYCOSORB AND PROTEIN A IMMUNOADSORPTION IN AB0-INCOMPATIBLE-KIDNEY TRANSPLANTATION
DIFFERENCES BETWEEN LIVE AND DECEASED-DONOR KIDNEY TRANSPLANTATION IN A CENTRE PERFORMING PROTOCOL BIOPSIES
EARLY SURGICAL COMPLICATIONS COMPROMISE LONG TERM SURVIVAL AFTER LIVING-RELATED KIDNEY TRANSPLANTATION
SEVERE ANEMIA DUE TO PARVO VIRUS B19 INFECTION IN A PATIENT AFTER LIVING DONOR KIDNEY TRANSPLANTATION - SUCCESSFUL TREATMENT USING HIGH-DOSE IMMUNOGLOBULINS
LIVING DONOR SMALL BOWEL TRANSPLANTATION FOR HYPOGANGLIONOSIS
LIVING DONOR NEPHRECTOMY - A SINGLE-CENTER EXPERIENCE WITH OPEN AND LAPAROSCOPIC APPROACHES
PRE-TRANSPLANT IMMUNE STATE IS ASSOCIATED WITH ACUTE REJECTION AFTER LIVING-DONOR KIDNEY TRANSPLANTATION
HIGH-URGENCY RENAL TRANSPLANTATION: INDICATIONS AND LONG-TERM OUTCOMES
RECURRENCE OF IDIOPATHIC MEMBRANOUS NEPHROPATHY 12 YEARS AFTER KINDEY TRANSPLANTATION - SUCCESSFUL TREATMENT WITH RITUXIMAB
NON-INVASIVE SCREENING FOR ACUTE REJECTION IN MURINE RENAL TRANSPLANTATION USING DIFFUSION WEIGHTED MRI
GLOMERULAR ENDOTHELIAL MICRORNA EXPRESSION PROFILES IN AN IN-VITRO MODEL OF ACUTE HUMORAL REJECTION
THE TREATMENT WITH EPOETIN THETA (BIOPOIN®) IN PATIENTS WITH RENAL ANEMIA IS EFFECTIVE, SAFE AND WELL ACCEPTED
SURGICAL MANAGEMENT AND OUTCOME OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE IN PATIENTS BEFORE AND AFTER RENAL TRANSPLANTATION
AUTOTRANSPLANTATION FOR THE TREATMENT OF SEVERE RENAL ARTERY STENOSIS AND ANEURYSM IN A SOLITARY KIDNEY AFTER REPEATED COILING: A CASE REPORT
6 CASES OF SUCCESSFUL DELIVERY AFTER COMBINED KIDNEY-PANCREAS TRANSPLANT: A SINGLE CENTER REPORT
INFLUENCE OF DIALYSIS MODALITY ON OUTCOME AFTER SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION
MANAGEMENT OF PANCREATIC FISTULA FOLLOWING PANCREAS TRANSPLANTATION
DEMOGRAPHIC CHALLENGES OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION (SPKT) 2005 TO 2012: A SINGLE-CENTER EXPERIENCE
HYPERACUTE REJECTION OR ISCHEMIA-REPERFUSION INJURY? SCRUTINY OF AN INTRAOPERATIVE PRIMARY ALLOGRAFT NONFUNCTION OF A SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT
METABOLIC FOLLOW-UP FOUR YEARS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION WITH PORTAL VENOUS VERSUS SYSTEMIC VENOUS DRAINAGE
UTILIZING A CLINICAL PATHWAY FOR LIVER TRANSPLANTATION: FIRST LESSONS LEARNT
LIVER GRAFT PERFUSION IN CHILDREN AFTER COMBINED LIVER-KIDNEY TRANSPLANTATION VERSUS SINGLE LIVER TRANSPLANTATION - A MATCHED-PAIR ANALYSIS
PORTAL VEIN THROMBOSIS IN LIVER TRANSPLANTATION: A SINGLE CENTER ANALYSIS
SURGICAL COMPLICATIONS REQUIRING EARLY REOPERATION ARE ASSOCIATED WITH POOR LONG-TERM OUTCOME AFTER LIVER TRANSPLANTATION
PRAISE: A PROSPECTIVE, MULTI-CENTER, RANDOMIZED, DOUBLE BLINDED, PLACEBO-CONTROLLED STUDY FOR THE EVALUATION OF ILOPROST IN THE EARLY POSTOPERATIVE PERIOD AFTER LIVER TRANSPLANTATION. THE STUDY PROTOCOL.
CYBERKNIFE® RADIOSURGERY AS A POTENTIAL TOOL FOR BRIDGING TO LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND LIVER CIRRHOSIS
APOA-I AMYLOIDOSIS CAUSES SEVERE HEPATIC INVOLVEMENT IN THE ABSENCE OF CLINICAL AND LABORATORY SIGNS OF LIVER DYSFUNCTION
TREATMENT OF POST-TRANSPLANT OSTEOPATHY AFTER LIVER TRANSPLANTATION: A FIVE-YEAR FOLLOW-UP
THROMBEMBOLIC COMPLICATION IN A PATIENT WITH ACTIVATED PROTEIN C RESISTANCE AFTER ORTHOTOPIC LIVER TRANSPLANTATION
EX-SITU-BACK TABLE PERFUSION DOES NOT PREVENT ISCHEMIC TYPE BILIARY LESIONS. A PROSPECTIVE RANDOMIZED CONTROLLED MULTI-CENTER STUDY ON LIVER PRESERVATION BY AORTIC PERFUSION WITH HTK SOLUTION COMPARED TO AORTIC PERFUSION PLUS ARTERIAL EX-SITU PERFUSION.
PNPLA3 IN END-STAGE LIVER DISEASE: ALCOHOL CONSUMPTION, HCC DEVELOPMENT AND LIVER TRANSPLANTATION
PREDICTING SURVIVAL AFTER LIVER TRANSPLANTATION FOR ACUTE LIVER FAILURE BY PREOPERATIVE RECIPIENT FACTORS: MYTH OR FACT?
PREDICTION OF EARLY ALLOGRAFT DYSFUNCTION IN LIVER TRANSPLANTATION
THE REGENERATIVE CAPACITY OF THE BILIARY EPITHELIUM INFLUENCES BILIARY COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION
REGULATION OF LIVER LOBE SIZE IN CASE OF CONCURRENT CONTRADICTORY SIGNALS
PULSE OXIMETRY IS INSUFFICIENT FOR TIMELY DIAGNOSIS OF HEPATOPULMONARY SYNDROME IN CHILDREN WITH LIVER CIRRHOSIS
ISCHEMIA TIME IS AN IMPORTANT PREDICTOR OF RECURRENCE-FREE SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH HEPATOCELLULAR CARCINOMA
RESPONSE TO TACE ALLOW IDENTIFICATION OF SUITABLE PATIENTS WITH HEPATOCELLULAR CARCINOMA FOR LIVER TRANSPLANTATION
IMPORTANCE OF PERIBILIARY MICROCIRCULATORY IMPAIRMENT FOR THE GENERATION AND FATE OF EARLY ISCHEMIC TYPE BILIARY LESIONS AFTER LIVER TRANSPLANTATION
INCREASED PRETRANSPLANT CRP LEVEL IS AN INDEPENDENT PREDICTOR OF MORTALITY IN LIVER TRANSPLANT PATIENTS WITH (LAB)MELD ≥ 30
STATUS QUO AND COMPETITION OF LIVER TRANSPLANT CENTERS IN GERMANY
PROJECTED CASELOAD FOR TRANSPLANT CENTERS TO OFFER TRAINING IN TRANSPLANT SURGERY ACCORDING TO THE REQUIREMENTS OF THE EUROPEAN BOARD OF SURGERY
20-HYDROXYEICOSATETRAENOIC ACID (20-HETE) OVERPRODUCTION AGGRAVATES ISCHEMIC ACUTE KIDNEY INJURY IN MICE DEFICIENT FOR SOLUBLE EPOXYDE HYDROLASE (SEH) GENE
RADIOTHERAPY INCREASES STEM-CELLNESS OF HEPATOCELLULAR CARCINOMA CELLS
COMBINED THERAPY WITH CLOPIDOGREL AND EVEROLIMUS RESULTS IN SIGNIFICANT REDUCTION OF SKIN ALLOGRAFT REJECTION IN A MURINE TRANSPLANT MODEL
STEM CELL TRANSPLANTATION IN REGENERATIVE MEDICINE: AGE DEPENDENT DIFFERENCES IN STEM CELL BEHAVIOUR
VISUALIZATION OF HEPATIC VASCULAR ANATOMY IN RODENTS
CONTRAST ENHANCED T-CELL TARGETED ULTRASOUND FOR DETECTION OF ACUTE REJECTION IN RAT RENAL TRANSPLANTATION
IL-13 SIGNALING VIA IL-13Rα2 TRIGGERS TGF-β1 DEPENDENT ALLOGRAFT FIBROSIS
LEUKOCYTIC ACETYLCHOLINE INHIBITS ATP-MEDIATED IL-1β RELEASE IN RAT RENAL ALLOGRAFTS
INHIBITION OF 12/15-LIPOXYGENASE PREVENTS CELL DEATH AFTER HEPATIC ISCHEMIA AND REPERFUSION
OVEREXPRESSION OF CUZNSOD IMPROVES ENGRAFTMENT OF TRANSPLANTED HEPATOCYTES IN ATP7B KNOCKOUT MICE
THE FUNCTIONAL INFLUENCE OF ACTIVATING NATURAL KILLER CELL RECEPTORS IN SOLID ALLOGRAFT REJECTION
DOUBLE-DEFICIENCY FOR RORγT AND T-BET DRIVES TH2-MEDIATED ALLOGRAFT REJECTION IN MICE
SPECIFIC TOLERANCE-INDUCING EFFECTS OF EXTRACORPORAL PHOTOPHERESIS
PRECONDITIONING USING TETRAHYDROBIOPTERIN SAVES MURINE PANCREATIC ISOGRAFTS FROM BRAIN DEATH EXACERBATED ISCHEMIA REPERFUSION INJURY
N-OCTANOYL DOPAMINE INHIBITS SMOOTH MUSCLE CELL PROLIFERATION: POSSIBLE IMPLICATIONS FOR PREVENTION OF NEO-INTIMA FORMATION IN TRANSPLANTED GRAFTS
AUGMENTER OF LIVER REGENERATION ATTENUATES POSTISCHEMIC LIVER INJURY IN VIVO
THE PUTATIVE TUMOR SUPPRESSOR MICRORNA-105 NEGATIVELY REGULATES THE FRIZZLED-7/BETA-CATENIN PATHWAY IN HUMAN HEPATOCELLULAR CARCINOMA
NK-CELLS' POTENTIAL TO MODULATE ALLOANTIGEN INDUCED T-CELL RESPONSES IN RAT CAN BE INFLUENCED BY GENETIC POLYMORPHISMS WITHIN THE NATURAL KILLER GENE COMPLEX